New report from The Royal College of Physician: positive impact of E-Cigarettes

The Royal College of Physicians has assessed the available evidence on the use of e-cigarettes, from health effects to the issue of youth vaping, publishing a report with over 50 recommendations. It concluded that e-cigarettes represent a valuable aid in smoking cessation, but that much more can and should be done to reduce their appeal, availability and affordability to people who do not smoke, including children and young people, and reduce environmental harms. 

Continue ReadingNew report from The Royal College of Physician: positive impact of E-Cigarettes

CoEHAR Founder Riccardo Polosa adresses the Australian Senators on vaping reform

According to the studies, “CoEHAR research in patients with COPD patients, asthma, high blood pressure, schizophrenia show clear benefits with objective evidence for harm reversal after switching from smoking.. and also showed that lung function and respiratory symptoms and muco-ciliary clearance improve after switching from smoking to vaping”.

Continue ReadingCoEHAR Founder Riccardo Polosa adresses the Australian Senators on vaping reform

CoEHAR welcomes the International partners of Replica

“We would like to thank all the partners for accepting to continue this important partnership with the new edition of the Replica Project” stated Prof. Giovanni Li Volti, recently reconfirmed COEHAR Director “The goal for this new session of experiments is to replicate published scientific works dealing with the impact of cigarette smoke and RRP on the progression of cancer and in particular to molecular mechanisms of chemoresistance. In particular, the result of such studies will make also the difference in terms of harm reduction strategies for a particular vulnerable population of patients and improve the quality of their life in terms of life expectancy and adverse reactions to chemotherapy”

Continue ReadingCoEHAR welcomes the International partners of Replica

MAGNIFICAT: published the innovative protocol on dual users and harm reduction potential

The MAGNIFICAT study, strongly advocated by Prof. Riccardo Polosa, will evaluate the effects of the combined use of conventional cigarettes and electronic cigarettes on human health, quantifying this impact by collecting samples, researching and describing the core of different levels of dual use on exposure to toxic substances and harm reduction, and using specific biomarkers, clinical endpoints, and behavioral correlations

Continue ReadingMAGNIFICAT: published the innovative protocol on dual users and harm reduction potential

HOW TO REDUCE THE HARM CAUSED BY CIGARETTE SMOKE ON ORAL HEALTH AND TEETH?

The data from these works as a whole can be used to assess the impact in terms of risk/benefit ratio of the regular use of combustion-free products, assisting the efforts of public health authorities in encouraging smokers to quit, especially those who perceive their smoke-damaged smile as a barrier to personal health or work and social relationships.

Continue ReadingHOW TO REDUCE THE HARM CAUSED BY CIGARETTE SMOKE ON ORAL HEALTH AND TEETH?

Groundbreaking Global Initiative to Investigate Oral Health Impacts of Combustion-Free Nicotine Delivery Alternatives: the SMILE Study

The study has been designed with the help of experts from Germany, UK, Italy, Poland, Moldova, and Indonesia. SMILE study is being conducted in four dental clinics across four different countries (Italy, Poland, Moldova, and Indonesia). Volunteer enrollment was completed in August 2023 and results will be expected to be available in 2025.

Continue ReadingGroundbreaking Global Initiative to Investigate Oral Health Impacts of Combustion-Free Nicotine Delivery Alternatives: the SMILE Study